SLC6A3 and Parkinson disease: in patients with Parkinson’s disease (PD) and parkinsonism based on the anatomical subregions of the striatum found that the loss of dopamine transporters differed across the striatal subregions among diseases and can be used for disease differentiation (Oh et al., 2012; Sung et al., 2017; Kong et al., 2020).